Shenxia Xie
- Oncology
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Biology
- Immunology
- Biomedical Engineering
- Topics
- CAR-T cell therapy research (11 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)Immunotherapy and Immune Responses (5 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Shenxia Xie
14 papers receiving 268 citations
Peers
Comparison fields: 5 of 40
- Oncology 148
- Radiology, Nuclear Medicine and Imaging 114
- Molecular Biology 96
- Immunology 96
- Biomedical Engineering 72
Countries citing papers authored by Shenxia Xie
This map shows the geographic impact of Shenxia Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenxia Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenxia Xie more than expected).
Fields of papers citing papers by Shenxia Xie
This network shows the impact of papers produced by Shenxia Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenxia Xie. The network helps show where Shenxia Xie may publish in the future.
Co-authorship network of co-authors of Shenxia Xie
This figure shows the co-authorship network connecting the top 25 collaborators of Shenxia Xie. A scholar is included among the top collaborators of Shenxia Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenxia Xie. Shenxia Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 16 | |
| 6 | 16 | |
| 7 | 16 | |
| 8 | 33 | |
| 9 | 8 | |
| 10 | 54 | |
| 11 | 86 | |
| 12 | 5 | |
| 13 | 14 | |
| 14 | 2 | |
| 15 | 15 |
About Shenxia Xie
Shenxia Xie is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 270 indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Oncology (148 citations), Radiology, Nuclear Medicine and Imaging (114 citations) and Immunology (96 citations). Shenxia Xie has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Xiaoling Lü, Xiaomei Yang, Aiqun Liu, Shihua Yin, Fengzhen Mo, Shuyang Sun, Xiaoqiong Hou, Qu Chen, Wei Shi and Siliang Duan. Their work appears in journals such as Chemistry - A European Journal, Cancer Letters and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.